[fcb5af]: / literature / by_gene / PIK3R1.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 33401995 10.1080/08820139.2020.1863982 2022 The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS). PIK3R1
2 34382383 10.3324/haematol.2020.263251 2022 Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma. PIK3R1
3 34799485 10.1097/PAS.0000000000001834 2022 Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation. PIK3R1
4 34831026 10.3390/cells10112803 2022 Fluctuations in AKT and PTEN Activity Are Linked by the E3 Ubiquitin Ligase cCBL. PIK3R1
5 35990641 10.3389/fimmu.2022.937872 2022 Genomic crossroads between non-Hodgkin's lymphoma and common variable immunodeficiency. PIK3R1
6 33512474 10.1182/blood.2020006528 2021 CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1. PIK3R1
7 33757561 10.1186/s13104-021-05521-y 2021 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL). PIK3R1
8 34249806 10.3389/fped.2021.652405 2021 Activated PI3Kinase Delta Syndrome-A Multifaceted Disease. PIK3R1
9 34307262 10.3389/fped.2021.702546 2021 Case Report: Hodgkin Lymphoma and Refractory Systemic Lupus Erythematosus Unveil Activated Phosphoinositide 3-Kinase-δ Syndrome 2 in an Adult Patient. PIK3R1
10 34352450 10.1016/j.jaip.2021.07.044 2021 Clinical Manifestations and Outcomes of Activated Phosphoinositide 3-Kinase δ Syndrome from the USIDNET Cohort. PIK3R1
11 34447369 10.3389/fimmu.2021.671755 2021 Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. PIK3R1
12 34604146 10.3389/fped.2021.757229 2021 Corrigendum: Case Report: Hodgkin Lymphoma and Refractory Systemic Lupus Erythematosus Unveil Activated Phosphoinositide 3-Kinase-δ Syndrome 2 in an Adult Patient. PIK3R1
13 31918102 10.1016/j.chemosphere.2019.125794 2020 Antagonistic effect of selenium on lead-induced neutrophil apoptosis in chickens via miR-16-5p targeting of PiK3R1 and IGF1R. PIK3R1
14 31942637 10.1182/blood.2019002072 2020 Increased activation of PI3 kinase-δ predisposes to B-cell lymphoma. PIK3R1
15 32936972 10.1002/ajh.25998 2020 A novel germline variant in PIK3R1 results in SHORT syndrome associated with TAL/LMO T-cell acute lymphoblastic leukemia. PIK3R1
16 28895406 10.4149/neo_2017_603 2019 Identification of potential key genes associated with diffuse large B-cell lymphoma based on microarray gene expression profiling. PIK3R1
17 29643030 2019 [Screening and verification of key genes in T-cell acute lymphoblastic leukemia]. PIK3R1
18 29857068 10.1016/j.jid.2018.04.038 2019 Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. PIK3R1
19 28561224 10.1055/s-0043-104218 2018 Variant PIK3R1 Hypermorphic Mutation and Clinical Phenotypes in a Family with Short Statures, Mild Immunodeficiency and Lymphoma. PIK3R1
20 27221134 10.1016/j.jaci.2016.03.022 2017 Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study. PIK3R1
21 28671688 10.1038/ng.3909 2017 The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. PIK3R1
22 28694326 10.1182/blood-2017-02-768234 2017 Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E). PIK3R1
23 28978570 10.1182/blood-2017-06-792184 2017 Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia. PIK3R1
24 25951043 10.1080/15548627.2015.1017192 2016 The role of STAT3 in autophagy. PIK3R1
25 26210919 10.1016/j.plefa.2015.06.003 2016 Phosphorylation of serine 523 on 5-lipoxygenase in human B lymphocytes. PIK3R1
26 26251039 10.1111/cas.12766 2016 Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia. PIK3R1
27 24659799 10.1242/jcs.141689 2015 Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion. PIK3R1
28 25227228 10.1534/g3.114.013482 2015 The genome of the chicken DT40 bursal lymphoma cell line. PIK3R1
29 25956014 10.1016/j.jaci.2015.02.037 2015 Advances in basic and clinical immunology in 2014. PIK3R1
30 24418330 10.1186/1479-5876-12-10 2014 Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma. PIK3R1
31 23143597 10.1038/ng.2468 2013 The genetic landscape of mutations in Burkitt lymphoma. PIK3R1
32 23215766 10.3109/08830185.2012.737073 2013 HIV-1 Nef in macrophage-mediated disease pathogenesis. PIK3R1
33 23292937 10.1073/pnas.1205299110 2013 Genetic heterogeneity of diffuse large B-cell lymphoma. PIK3R1
34 23341541 10.1182/blood-2012-10-460832 2013 P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse. PIK3R1
35 23603894 10.1254/jphs.12149fp 2013 Inhibition of the PI3K/AKT-NF-κB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt's lymphoma. PIK3R1
36 22609116 10.1016/j.ajpath.2012.03.013 2012 Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma. PIK3R1
37 21077741 10.3109/10428194.2010.530360 2011 Posttranscriptional regulation of the p85α adapter subunit of phosphatidylinositol 3-kinase in human leukemia cells. PIK3R1
38 21266193 10.1016/j.ygeno.2011.01.005 2011 Differential expression of immune-associated cancer regulatory genes in low- versus high-dose-rate irradiated AKR/J mice. PIK3R1
39 19406940 10.1210/en.2009-0212 2009 Computational and functional analysis of growth hormone (GH)-regulated genes identifies the transcriptional repressor B-cell lymphoma 6 (Bc16) as a participant in GH-regulated transcription. PIK3R1
40 18704194 10.1172/JCI33337 2008 Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells. PIK3R1
41 16289966 10.1016/j.cellsig.2005.10.001 2006 Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav. PIK3R1
42 14530346 10.4049/jimmunol.171.8.4227 2004 Dual phosphorylation of phosphoinositide 3-kinase adaptor Grb2-associated binder 2 is responsible for superoxide formation synergistically stimulated by Fc gamma and formyl-methionyl-leucyl-phenylalanine receptors in differentiated THP-1 cells. PIK3R1
43 14968112 10.1038/sj.onc.1207398 2004 Identification of NPM-ALK interacting proteins by tandem mass spectrometry. PIK3R1
44 11986952 10.1038/sj.leu.2402484 2002 Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO). PIK3R1
45 11157475 10.1182/blood.v97.3.608 2001 SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways. PIK3R1
46 9233773 10.1038/sj.onc.1201163 1997 Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation. PIK3R1
47 9259313 10.1210/mend.11.9.9980 1997 Phosphorylation of cbl after stimulation of Nb2 cells with prolactin and its association with phosphatidylinositol 3-kinase. PIK3R1
48 8766817 10.1016/0014-5793(96)00552-2 1996 Sam68 from an immortalised B-cell line associates with a subset of SH3 domains. PIK3R1
49 8896416 1996 The protein product of the proto-oncogene c-cbl forms a complex with phosphatidylinositol 3-kinase p85 and CD19 in anti-IgM-stimulated human B-lymphoma cells. PIK3R1
50 8294442 1994 Identification of two SH3-binding motifs in the regulatory subunit of phosphatidylinositol 3-kinase. PIK3R1